The psilocybin trip was never the problem. The problem is the system that caged it, commodified it, and sold it back to us as therapy for the rich. Magic mushrooms once carried healing without a bill, but now the price of entry looks like a mortgage. Psychedelic therapy isn’t liberation. It’s capitalism with incense. The shrooms are real.
The cure was growing under our feet all along
The smell of cow shit and rain-soaked grass. That’s where psilocybin grew before lab coats and clipboards. Nature dropped medicine for free. No copays. No billing codes. Just dirt under your fingernails and visions in your skull.
Indigenous people didn’t call them hacks. They called them teachers. They didn’t sell microdose chocolates at pop-ups. They ran ceremonies that cracked your ego in half. Then the Controlled Substances Act of 1970 erased it all, slotting psilocybin into Schedule I—“no medical use.” Meanwhile booze got Super Bowl ads and Oxy got prescriptions. That wasn’t science. That was politics.
Now the same drug is back. Except you need thousands of dollars and a “facilitator” who can’t even call it medicine. COMPASS Pathways and ATAI patent molecules older than dirt. Oregon clinics sell “sessions” like spa days. The fungi didn’t change. The system did.
This isn’t innovation. It’s repossession. Shrooms were sacred until profit made them contraband.
Therapy without therapists is just vibes with paperwork
Picture it. A candlelit room. A “guide” who legally can’t diagnose, prescribe, or claim healing. They just sit there, watching. You call it therapy. The state calls it “psilocybin services.” The bill calls it robbery.
Oregon designed the loophole on purpose. No medical claim means no liability. They sell the vibe, not the cure. It’s paperwork with incense. According to the Oregon Psilocybin Services board, over 22,000 doses were administered since 2023, with 12 emergency calls. The state brags that only 12 people panicked hard enough to need 911. That’s their metric for success.
Meanwhile, some Oregon cities flat-out banned psilocybin. Portland calls it progress. Salem calls it a crime. Cross the wrong county line and your trip ends in handcuffs. Legalization isn’t freedom. It’s a fucking lottery.
Oregon sold support. People heard therapy.
Placebo is doing more adulting than the drug
The microdosing craze tastes like kombucha and tech bro sweat. Founders nibble shrooms before pitch meetings. Wellness influencers sell half-trips as “self-care.” Microdosing became the adulting hack. Productivity in a capsule.
Except the science dragged it into the dirt. Placebo-controlled trials found no meaningful cognitive boost. Self-blinding studies showed no difference between placebo and microdose. EEG scans said your creativity isn’t spiking. The only thing working overtime is your expectations.
But the culture loves the delusion. Microdosing flatters hustle culture. It promises enlightenment without risk. It’s vibes without surrender. No collapse. No ego death. Just a little drip of “wellness” you can still take to a board meeting. That’s why Silicon Valley ran with it. It keeps workers grinding. It keeps you thinking you’re evolving while you’re just paying rent with new vocabulary.
Microdosing is a vibe tax on your expectations.
Primary endpoints don’t care about your vibe. Just vibe off shrooms, already.
The trial room doesn’t smell like sage. It smells like bleach and anxiety. Patients swallow psilocybin. Some get placebo. Scientists check boxes. At first, depression scores drop. Headlines scream miracle. Investors salivate.
Then the data lands. In the NEJM trial, psilocybin was no better than escitalopram on the primary outcome. In other studies, blinding collapsed because everyone knew who was high. Expectation bled into results. COMPASS Pathways’ phase 3 claims look shiny, but peer-reviewed journals haven’t confirmed. The hype is louder than the science.
And the risks? They’re not whispers. They’re panic spikes, mania, flashbacks. Psilocybin is low-tox, but the mind isn’t bulletproof. It’s not “safe and natural.” It’s volatile. It cuts as much as it heals.
Psychedelic therapy might change lives. But it’s not magic. Trials don’t run on hope. They run on endpoints.
The future of healing won’t be sold by the hour.
In Oregon, a single psilocybin session costs thousands. No insurance. No subsidy. Just cash. Clinics open, struggle, collapse. Patients mortgage their hope. Facilitators scrape to survive. Healing isn’t rare. Access is.
Meanwhile, corporations patent compounds they didn’t invent. COMPASS Pathways and ATAI Life Sciences file paperwork on molecules that grow freely in pastures. Investors get rich while communities that carried the medicine for centuries get priced out. It’s colonization with a lab coat.
Equity promises are vapor. Marginalized people—the ones most mangled by trauma—can’t afford boutique wellness. Psilocybin becomes another wellness toy for the privileged. Everyone else waits outside the velvet rope.
The fungi are still free. They still grow in fields. They don’t need your debit card. They don’t need a facilitator. What costs is legality. What costs is permission. What costs is capitalism disguising itself as healing.
Shrooms aren’t expensive. Capitalism makes them expensive.
